These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28381170)

  • 21. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
    Cheng MW; Shen ZT; Hu GY; Luo LG
    Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of junctional adhesion molecule-A and EphB2 predicts poor survival in lung adenocarcinoma patients.
    Zhao C; Wang A; Lu F; Chen H; Fu P; Zhao X; Chen H
    Tumour Biol; 2017 Feb; 39(2):1010428317691000. PubMed ID: 28231727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma.
    Wang H; Wang W; Wang X; Cai K; Wu H; Ju Q; Huang Z; Gao X
    Med Oncol; 2012 Dec; 29(5):3162-8. PubMed ID: 22528516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of ASCL2 is an independent prognostic indicator in lung squamous cell carcinoma.
    Hu XG; Chen L; Wang QL; Zhao XL; Tan J; Cui YH; Liu XD; Zhang X; Bian XW
    J Clin Pathol; 2016 Apr; 69(4):313-8. PubMed ID: 26483561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases.
    Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Hirata M; Momose M; Date H; Haga H
    Histopathology; 2017 Jan; 70(2):232-241. PubMed ID: 27467545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
    Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
    Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.
    Sato Y; Fujimoto D; Uehara K; Shimizu R; Ito J; Kogo M; Teraoka S; Kato R; Nagata K; Nakagawa A; Otsuka K; Hamakawa H; Takahashi Y; Imai Y; Tomii K
    BMC Cancer; 2016 Nov; 16(1):890. PubMed ID: 27842505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
    Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
    Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
    Shen QM; Wang HY; Xu S
    Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of programmed cell death 1 ligand 1 in lung adenocarcinoma is a poor prognostic factor particularly in smokers and wild-type epidermal growth-factor receptor cases.
    Mori S; Motoi N; Ninomiya H; Matsuura Y; Nakao M; Mun M; Okumura S; Nishio M; Morikawa T; Ishikawa Y
    Pathol Int; 2017 Jan; 67(1):37-44. PubMed ID: 27976463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALDH3B1 Is an Independent Prognostic Biomarker of Lung Adenocarcinoma.
    Sun H; Zhang M; Li L; Huang Z
    Technol Cancer Res Treat; 2020; 19():1533033820946018. PubMed ID: 32744175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study.
    Chang CC; Sung WW; Hsu HT; Yeh CM; Lee CH; Chen YL; Liu TC; Yeh KT
    BMJ Open; 2018 Jun; 8(6):e021385. PubMed ID: 29934389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
    Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
    Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K; Maeda A; Yukawa T; Nojima Y; Saisho S; Okita R; Nakata M
    World J Surg Oncol; 2014 Nov; 12():343. PubMed ID: 25392182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.
    Eguchi T; Kadota K; Chaft J; Evans B; Kidd J; Tan KS; Dycoco J; Kolquist K; Davis T; Hamilton SA; Yager K; Jones JT; Travis WD; Jones DR; Hartman AR; Adusumilli PS
    Oncotarget; 2016 Jun; 7(23):35241-56. PubMed ID: 27153551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of ACP5 expression in patients with lung adenocarcinoma.
    Gao YL; Liu MR; Yang SX; Dong YJ; Tan XF
    Clin Respir J; 2018 Mar; 12(3):1100-1105. PubMed ID: 28398694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.